Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive approach. Advocates often highlight the possibility for meaningful therapeutic gains, principally in diseases where conventional therapies have proven inadequate. However, it's to assess the considerable financial investment associated with CPI stem cell therapy, i